Taiwan FDA registration e34412185772c688fa9fe87295aa169d
“Abbott” Afinion Lipid Panel Control
TW: “亞培” 艾菲寧脂質檢驗品管組
Taiwan·Risk Class 2·MD·ABBOTT DIAGNOSTICS TECHNOLOGIES AS·Registered May 06, 2016 – May 06, 2026ExpiredRegistration details
- Analysis ID
- e34412185772c688fa9fe87295aa169d
- License Form
- Ministry of Health Medical Device Import No. 028421
- Customs Code
- DHA05602842103
Company information
- Manufacturer
- ABBOTT DIAGNOSTICS TECHNOLOGIES AS
- Manufacturer Country
- Norway
- Authorized Representative
- Abbott Rapid Diagnostics Health Corp.
Product details
- Intended Use
- This product is suitable for total cholesterol (Chol), high-density lipoprotein (HDL) cholesterol and triglycerides (Trig) test quality control substances.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- May 06, 2016
- Expiry Date
- May 06, 2026
About this record
Access comprehensive regulatory information for “Abbott” Afinion Lipid Panel Control in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e34412185772c688fa9fe87295aa169d and manufactured by ABBOTT DIAGNOSTICS TECHNOLOGIES AS. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices